eResearch Technology launches eSafety Net for post-market safety surveillance service



The service is designed to provide drug and device companies with an automated safety data system, which utilizes physician front-end support to enable the effective management of global adverse reactions occurring anywhere in the clinical trial process.

eRT previously formed a partnership with Medical Advisory Systems (MAS), to utilize its 24/7 physician-based system designed to accept information directly from the reporter, therefore improving the quality and timeliness of data. This data is then entered into eRT's Web-enabled applications, allowing for immediate and appropriate review. Through MAS's partnership with CORIS, eRT can provide this 24/7 physician-based system to 37 countries worldwide.

"The traditional approach to safety surveillance is a slow process with incomplete data collection, minimal physician involvement, costly personnel placement and incomplete follow-up," said Jeffery Litwin, CMO and Senior Vice President of eRT. "eRT's eSafety Net Service compresses the time to reporting by collecting data faster, with early physician involvement and 24/7 access to real-time data via eRT's Research Dashboard."

"eSafety Net Service enables our clients to focus on the discovery, development and commercialisation of potential drug candidates, while managing the risks associated with the use of pharmaceutical and biologic products and/or medical devices," said Joseph Esposito, President and CEO of eRT. "This service compliments our eSafety Net software application."